Skip to main content
Clinical Trials/NCT03528668
NCT03528668
Completed
Not Applicable

Patient Receptiveness to Using Virtual Reality as a Distractor From Pain

Massachusetts General Hospital1 site in 1 country89 target enrollmentApril 16, 2018
ConditionsPainAnxiety

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain
Sponsor
Massachusetts General Hospital
Enrollment
89
Locations
1
Primary Endpoint
Change in Pain
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study will evaluate the acceptability, use, and general effect that exposure to virtual reality has on hospitalized patients reporting at least one discomfort including recent or current moderate-severe pain.

Detailed Description

Patients with moderate-severe pain will be approached with approval of nursing staff and front line nurse manager who determine their appropriateness for a trial of virtual reality (VR) exposure for up to 30 minutes. The trial and use of VR will be explained after meeting the inclusion criteria and they will be asked about their level of interest in trying the VR headset. If interested, the subject will indicate their verbal consent to proceed with the VR trial. They will be asked about any baseline discomforts of pain, anxiety/stress or other discomfort; which will be rated on a 0-10 numeric (visual analog) scale. A baseline heart rate will be recorded in beats per minute. The headset will be applied and adjusted for comfort, then the app will be started along with a timer to track the duration of their use up to a maximum of 30 minutes. When the Headset is removed, the duration of use will be noted. The change in post-exposure heart rate (in beats per minute) and discomforts of pain, anxiety/stress or other discomforts (subtracting baseline from 5 minute post-exposure data) will be recorded. Subjects will be asked about the ease of use, whether or not they would use VR again, and for any other comments they would like to express. The headset will be disinfected between patient use.

Registry
clinicaltrials.gov
Start Date
April 16, 2018
End Date
October 12, 2018
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Paul Arnstein

Clinical Nurse Specialist

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • English-speaking
  • Inpatients on a general care unit
  • Current or recorded moderate to severe pain in past 24 hours

Exclusion Criteria

  • Receiving palliative/end of life care;
  • Admitted for treatment of psychiatric or mental health disorder
  • History of seizure or stroke
  • Legally blind or deaf
  • Moderate or severe cognitive impairment
  • Head wounds or bandages
  • On isolation precautions.

Outcomes

Primary Outcomes

Change in Pain

Time Frame: Change between baseline and 5 minutes after intervention

Change in subjective report of pain measured on a visual analog scale

Secondary Outcomes

  • Change in Heart Rate(Change between baseline and 5 minutes after intervention)
  • Change in Anxiety(Change between baseline and 5 minutes after intervention)

Study Sites (1)

Loading locations...

Similar Trials